Original Research Article
Molecular Psychiatry (2005) 10, 213–219. doi:10.1038/sj.mp.4001562 Published online 21 September 2004
Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients
K M R Prasad1, K V Chowdari1,2, V L Nimgaonkar1,2, M E Talkowski1,2, D A Lewis1,3 and M S Keshavan1
- 1Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 2Department of Human Genetics, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 3Department of Neuroscience, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Correspondence: Dr MS Keshavan, MD, Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. E-mail: KeshavanMS@upmc.edu
Received 31 March 2004; Revised 7 June 2004; Accepted 28 June 2004; Published online 21 September 2004.
Abstract
Polymorphisms of the gene encoding the regulator of G-protein signaling subtype 4 (RGS4) may confer risk for schizophrenia.1 DNA microarray studies of postmortem brain samples have shown RGS4 underexpression in the dorsolateral prefrontal cortex (DLPFC, area 9), motor and visual cortices in schizophrenia patients relative to control subjects.2 Underexpression of RGS4 in DLPFC is pathophysiologically significant because DLPFC pathology in schizophrenia has been supported by neurocognitive,3,4 structural5 and functional6,7 imaging, postmortem,8 cellular9,10 and molecular11 pathological studies. For these reasons, we examined the association of DLPFC gray matter volume with RGS4 polymorphisms in a series of antipsychotic-naïve first-episode schizophrenia patients and control subjects. We hypothesized that volumetric alterations of the DLPFC would be associated with RGS4 polymorphisms and that these differences would be more pronounced in patients than in controls. We observed robust volumetric differences across the genotypes in the pooled sample of patients and control subjects; when separately analyzed, we observed differences within the patient group (n=30) but not in control subject (n=27) group. The findings suggest that RGS4 polymorphisms may contribute to structural alterations in the DLPFC.
Keywords:
RGS4, genetic polymorphisms, schizophrenia, neuroanatomy, MRI, psychosis, prefrontal cortex
